Wis. maker of ablation devices nears financing target of $19M

08/1/2013 | MassDevice.com (Boston)

An equity financing round targeted at $19 million has pulled in $14 million for NeuWave Medical, a spinoff of the University of Wisconsin-Madison. The company is the maker of the Certus 140 soft-tissue ablation system, which is used primarily to aid in the treatment of kidney, liver and lung tumors.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL